Module
Managing Side Effects of HCV Therapy
Source: Hepatitis Annual Update 2005
Managing Side Effects of HCV Therapy
Program Director: Patrick J. Lynch, MD
|
Learning Objectives
Upon completion of this activity, participants should be able to:
Review the cytopenic complications associated with ribavirin therapy, including anemia, neutropenia, and thrombocytopenia. Describe the optimal management of hematologic complications due to interferon/ribavirin therapy. Discuss neuropsychiatric complications, retinopathy, and sarcoidosis associated with interferon/ribavirin therapy, and ways of managing these side effects.
Content includes:
- Strategies for Reducing Treatment-Related Side Effects: Reducing Treatment Duration
- Treatment-Related Neuropsychiatric Symptoms: Depression
- Male Sexual Dysfunction
- Fatigue
- Treatment-Related Cytopenias: Anemia
- Managing Amemia With Epoetin Alfa
- Reducing Anemia: Ribavirin Renal Dosing
- Treatment-Related Cytopenias: Neutropenia
- Treatment-Related Cytopenias: Thrombocytopenia
- Other Treatment-Related Adverse Events: Retinopathy
- Other Treatment-Related Adverse Events: Sarcoidosis
|
Disclaimer:
The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.
|
Jointly sponsored by Northwestern University’s Feinberg School of Medicine and Clinical Care Options, LLC.
Contact Info
Educational grants provided by:
Educational grants support only the CME-certified components of this program.
|
|